| Literature DB >> 35469142 |
Marco Lünich1, Kimon Kieslich1.
Abstract
In combating the ongoing global health threat of the COVID-19 pandemic, decision-makers have to take actions based on a multitude of relevant health data with severe potential consequences for the affected patients. Because of their presumed advantages in handling and analyzing vast amounts of data, computer systems of algorithmic decision-making (ADM) are implemented and substitute humans in decision-making processes. In this study, we focus on a specific application of ADM in contrast to human decision-making (HDM), namely the allocation of COVID-19 vaccines to the public. In particular, we elaborate on the role of trust and social group preference on the legitimacy of vaccine allocation. We conducted a survey with a 2 × 2 randomized factorial design among n = 1602 German respondents, in which we utilized distinct decision-making agents (HDM vs. ADM) and prioritization of a specific social group (teachers vs. prisoners) as design factors. Our findings show that general trust in ADM systems and preference for vaccination of a specific social group influence the legitimacy of vaccine allocation. However, contrary to our expectations, trust in the agent making the decision did not moderate the link between social group preference and legitimacy. Moreover, the effect was also not moderated by the type of decision-maker (human vs. algorithm). We conclude that trustworthy ADM systems must not necessarily lead to the legitimacy of ADM systems.Entities:
Keywords: Algorithmic decision-making; COVID-19; Decision legitimacy; Public opinion; Social group preference; Trust
Year: 2022 PMID: 35469142 PMCID: PMC9022054 DOI: 10.1007/s00146-022-01412-3
Source DB: PubMed Journal: AI Soc ISSN: 0951-5666
Fig. 1The conceptual model for the RQ1 and H1
Fig. 2Conceptual model for H2–H4
Reliability values
| Trust in ADM | ADM as viable solution | Trust in agent (ADM) | Trust in agent (human) | Legitimacy | |
|---|---|---|---|---|---|
| alpha | 0.95 | 0.94 | 0.97 | 0.97 | 0.95 |
| omega | 0.95 | 0.94 | 0.97 | 0.97 | 0.95 |
| omega2 | 0.95 | 0.94 | 0.97 | 0.97 | 0.95 |
| omega3 | 0.95 | 0.94 | 0.97 | 0.97 | 0.95 |
| avevar | 0.84 | 0.85 | 0.90 | 0.90 | 0.82 |
Measurement invariance trust
| TLI | RMSEA (90% CI) | Model comp | Δ | ΔTLI | ΔRMSEA | ||
|---|---|---|---|---|---|---|---|
| M1: configural invariance | 10.73* (4) | 1.00 | 0.05 (0.01–0.08) | ||||
| M2: metric invariance | 13.76 (7) | 1.00 | 0.03 (0.00–0.06) | M1 | 3.03 (3) | 0.00 | − 0.02 |
| M3: scalar invariance | 18.94* (10) | 1.00 | 0.03 (0.01–0.06) | M2 | 5.18 (3) | 0.00 | 0.00 |
| M4: residual invariance | 31.26* (14) | 1.00 | 0.04 (0.02–0.06) | M3 | 12.33* (4) | 0.00 | 0.01 |
*p < 0.05
aN = 1602
Measurement invariance legitimacy
| TLI | RMSEA (90% CI) | Model comp | Δ | ΔTLI | ΔRMSEA | ||
|---|---|---|---|---|---|---|---|
| M1: configural invariance | 134.23* (8) | 0.94 | 0.20 (0.17–0.23) | ||||
| M2: metric invariance | 146.93* (17) | 0.97 | 0.14 (0.12–0.16) | M1 | 12.71 (9) | 0.03 | − 0.06 |
| M3: scalar invariance | 157.65*(26) | 0.98 | 0.11 (0.10–0.13) | M2 | 10.72 (9) | 0.01 | − 0.03 |
| M4: residual invariance | 214.38* (38) | 0.98 | 0.11 (0.09–0.12) | M3 | 56.73* (12) | 0.00 | 0.00 |
*p < 0.05
aN = 1602
Latent factor model for the perceived viability of ADM for vaccine distribution
| Estimate (Std.Err.) | ||
|---|---|---|
| Viability of ADM | ||
| AK04.01 | 1.01(0.01) | 0.000 |
| AK04.02 | 1.02(0.01) | 0.000 |
| AK04.03 | 0.97(0.01) | 0.000 |
| AK04.01 | 0.06(0.03) | 0.044 |
| AK04.02 | – 0.11(0.03) | 0.000 |
| AK04.03 | 0.06(0.03) | 0.063 |
| Viability of ADM | 2.88(0.03) | 0.000 |
| Viability of ADM | 1.29(0.05) | 0.000 |
| 0.00(0) | ||
| CFI | 1.00 | |
| TLI | 1.00 | |
| RMSEA | 0.00 |
Structural regression model for the relationship between general trust in ADM and the viability of ADM for vaccine distribution
| Estimate (Std.Err.) | ||
|---|---|---|
| Viability of ADM | ||
| AK04.01 | 1.00(0.01) | 0.000 |
| AK04.02 | 1.02(0.01) | 0.000 |
| AK04.03 | 0.97(0.01) | 0.000 |
| General Trust in ADM | ||
| VT08.01 | 1.03(0.01) | 0.000 |
| VT08.02 | 1.00(0.01) | 0.000 |
| VT08.03 | 0.97(0.01) | 0.000 |
| VT08.04 | 1.00(0.01) | 0.000 |
| Viability of ADM | ||
| General Trust in ADM | 0.67(0.03) | 0.000 |
| AK04.01 | 0.06(0.03) | 0.032 |
| AK04.02 | – 0.12(0.03) | 0.000 |
| AK04.03 | 0.06(0.03) | 0.064 |
| VT08.01 | – 0.04(0.03) | 0.180 |
| VT08.02 | – 0.09(0.03) | 0.002 |
| VT08.03 | 0.04(0.03) | 0.138 |
| VT08.04 | 0.09(0.03) | 0.003 |
| Viability of ADM | 1.04(0.08) | 0.000 |
| General Trust in ADM | 2.76(0.02) | 0.000 |
| Viability of ADM | 0.88(0.03) | 0.000 |
| General Trust in ADM | 0.92(0.03) | 0.000 |
| Fit Indices | ||
| 28.38(13) | 0.008 | |
| RMSEA | 0.03 | |
| RMSEA.CI.LOWER | 0.01 | |
| RMSEA.CI.UPPER | 0.04 | |
| TLI | 1.00 |
Structural regression model for the relationship between disapproval of a social group’s vaccination prioritization and the legitimacy of early vaccination
| Estimate (Std.Err.) | ||
|---|---|---|
| Legitimacy of prioritization | ||
| LG04.01 | 1.00(0.01) | 0.000 |
| LG04.02 | 1.05(0.01) | 0.000 |
| LG04.03 | 0.95(0.02) | 0.000 |
| LG04.04 | 1.01(0.01) | 0.000 |
| Legitimacy of prioritization | ||
| Disapproval of early vaccination | – 0.66(0.06) | 0.000 |
| LG04.01 | 0.151(0.03) | 0.000 |
| LG04.02 | – 0.19(0.03) | 0.000 |
| LG04.03 | – 0.06(0.04) | 0.089 |
| LG04.04 | 0.10(0.04) | 0.000 |
| Legitimacy of prioritization | 3.34(0.04) | 0.000 |
| Legitimacy of prioritization | 1.31(0.05) | 0.000 |
| 174.47(23) | 0.000 | |
| RMSEA | 0.09 | |
| RMSEA.CI.LOWER | 0.08 | |
| RMSEA.CI.UPPER | 0.10 | |
| TLI | 0.98 |
Structural regression model for the moderation effect of trust in the agent making the decision
| Estimate(Std.Err.) | ||
|---|---|---|
| Legitimacy of prioritization | ||
| Trust in the agent | – 0.01(0.03) | 0.728 |
| Disapproval of early vaccination | – 0.66(0.06) | 0.000 |
| Disapproval of early vaccination * trust in the agent | 0.02(0.05) | 0.743 |
| Legitimacy of prioritization | 3.37(0.08) | 0.000 |
| Trust in the agent | 2.85(0.03) | 0.000 |
| Disapproval of early vaccination * trust in the agent | – 0.00(0.01) | 1.000 |
| Legitimacy of prioritization | 1.31(0.05) | 0.000 |
| Trust in the agent | 1.35(0.05) | 0.000 |
| Disapproval of early vaccination * trust in the agent | 0.34(0.01) | 0.000 |
| Trust in the agent w/disapproval of early vaccination * trust in the agent | 0.00(0.02) | 1.000 |
| 160.97(60) | 0.000 | |
| RMSEA | 0.03 | |
| RMSEA.CI.LOWER | 0.03 | |
| RMSEA.CI.UPPER | 0.04 | |
| TLI | 0.99 |
Structural regression model for the moderation effect of the agent making the decision
| HDM | ADM | |||
|---|---|---|---|---|
| Estimate (Std.Err.) | p | Estimate (Std.Err.) | p | |
| Legitimacy of prioritization | ||||
| Trust in the agent | – 0.01(0.03) | 0.649 | – 0.01(0.03) | 0.649 |
| Disapproval of early vaccination | – 0.66(0.06) | 0.000 | – 0.66(0.06) | 0.000 |
| Disapproval of early vaccination * trust in the agent | 0.07(0.07) | 0.360 | – 0.03(0.07) | 0.653 |
| Legitimacy of prioritization | 3.39(0.09) | 0.000 | 3.36(0.09) | 0.000 |
| Trust in the agent | 2.93(0.04) | 0.000 | 2.77(0.04) | 0.000 |
| Disapproval of early vaccination * trust in the agent | 0.00(0.02) | 0.962 | – 0.00(0.02) | 0.966 |
| Legitimacy of prioritization | 1.31(0.07) | 0.000 | 1.31(0.07) | 0.000 |
| Trust in the agent | 1.40(0.07) | 0.000 | 1.28(0.07) | 0.000 |
| Disapproval of early vaccination * trust in the agent | 0.35(0.02) | 0.000 | 0.32(0.02) | 0.000 |
| Trust in the agent w/disapproval of early vaccination * trust in the agent | 0.00(0.03) | 0.978 | 0.00(0.02) | 0.996 |
| χ2 | 316.58(141) | 0.000 | ||
| RMSEA | 0.04 | |||
| RMSEA.CI.LOWER | 0.03 | |||
| RMSEA.CI.UPPER | 0.05 | |||
| TLI | 0.99 | |||
Fixed parameter